Skip to main content
. 2017 Sep 22;9:187–192. doi: 10.2147/HIV.S141895

Table 2.

Cox regression analyses model of baseline predictors for HIV patients followed from 2010 to 2015 at general hospitals of Central Zone, Tigray, northern Ethiopia

Variable (n=638) Category Patient outcome
CHR (95% CI) AHR (95% CI)
Censored
Died
N (%) N (%)
Baseline CD4 cell count (cells/mm3) ≥350 314 (98.4) 5 (1.6) 1 1
<350 276 (86.5) 43 (13.5) 8.47 (3.35–21.38) 3.22 (1.17–8.82)
Sex Male 178 (89.5) 21 (10.5) 1.92 (1.08–3.39) 1.68 (0.86–3.31)
Female 412 (93.8) 27 (6.2) 1 1
Residence Urban 433 (95.4) 21 (4.6) 1 1
Rural 157 (85.3) 27 (14.7) 3.56 (2.01–6.31) 1.96 (1.05–3.68)
Marital status Unmarried 125 (91.2) 12 (8.8) 1 NI
Married 307 (93.9) 20 (6.1) 0.57 (0.28–1.18) NI
Divorced or widowed 158 (90.8) 16 (9.2) 0.92 (0.43–1.94) NI
Occupation Employed 173 (97.2) 5 (2.8) 1 1
Unemployed 417 (90.7) 43 (9.3) 3.76 (1.49–9.49) 2.70 (1.03–7.08)
Presence of any OI No 52 (78.8) 14 (21.2) 1 1
Yes 538 (94.1) 34 (5.9) 3.75 (2.01–6.98) 0.74 (0.37–1.46)
Baseline functional status Working 500 (96.7) 17 (3.3) 1 1
Ambulatory 66 (78.6) 18 (21.4) 7.53 (3.88–14.63) 2.54 (1.05–6.15)
Bedridden 24 (64.9) 13 (35.1) 12.78 (6.20–26.33) 2.98 (1.45–6.13)
Baseline hemoglobin level ≥11 mg/dL 497 (96.9) 16 (3.1) 1 1
<11 mg/dL 93 (74.4) 32 (25.6) 9.95 (5.45–18.15) 3.06 (1.51–6.23)
Baseline weight (kg) <40 44 (70.8) 18 (19.2) 5.54 (2.20–13.97) 1.95 (0.68–5.56)
40–60 449 (94.9) 24 (5.1) 0.89 (0.36–2.17) 0.66 (0.26–1.66)
>60 97 (94.2) 6 (5.8) 1 1
Baseline WHO stage I and II 396 (98.0) 8 (2.0) 1 NI
III and IV 194 (82.9) 40 (17.1) 9.45 (4.43–20.20) NI

Note: Data shown in bold indicates statistical significance (P<0.05).

Abbreviations: AHR, adjusted hazard ratio; CD4 cells, cluster of differentiation 4 cells; CHR, crude hazard ratio; CI, confidence interval; HIV, human immunodeficiency virus; NI, not included; OI, opportunistic illness; WHO, World Health Organization.